F2G Limited
- Address
- Laboratory B Ground Floor Block 50, Alderley House, Alderley Park
Sponsor Overview
Specializations
Invasive Fungal Infections
F2G Limited focuses on invasive fungal infections, with particular attention to disease caused by Aspergillus spp. and the clinical burden of invasive aspergillosis.
- Aspergillus-related infection
- Invasive aspergillosis
- Probable lower respiratory tract disease
Its clinical research activity is centred on treatment options for serious fungal disease across multiple active countries and collaborating sites.
Antifungal Therapeutics
The sponsor is engaged in antifungal therapy development, with interest in treatment strategies for patients needing targeted management of fungal pathogens.
- Novel antifungal treatment
- Systemic antifungal therapy
- Therapeutic response assessment
Research activity reflects a focus on improving options for difficult-to-treat fungal disease in clinical practice.
Severe Respiratory Infection
F2G Limited’s trial portfolio includes patients with lower respiratory tract disease linked to Aspergillus infection, highlighting interest in pulmonary manifestations of fungal illness.
- Pulmonary fungal disease
- Respiratory infection
- Clinical outcomes in lung involvement
This area connects antifungal treatment research with serious infections affecting the respiratory system.
Hospital-Based Infectious Disease Care
The sponsor’s clinical research is relevant to hospital-managed infectious disease, where patients with invasive fungal disease require specialist treatment and monitoring.
- Specialist inpatient care
- Severe infection management
- Clinical efficacy and safety evaluation
Its research footprint spans multiple sites across Europe and other active regions.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase III Randomized Study of Olorofim Versus Liposomal Amphotericin B in Patients with Invasive Aspergillosis |  Belgium France Germany Italy Spain The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 2 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 34 sites across their trial portfolio.
Therapeutic Focus
- 1.Bacterial Infections and Mycoses1 trial180 other sponsors
Partnered Research Centres
34 centres- Address
- Piazza Dell'ospedale Maggiore 3, 20162 Milan
- Address
- Ruddershove 10, 8000 Bruges
- Address
- Piazza Luigi Miraglia 2, 80138 Naples
- Address
- Largo Del Pozzo 71, 41124 Modena
- Address
- 3 Boulevard Alexandre Fleming, 25000 Besançon
- Address
- 1 Rue Jean Burguet, 33000 Bordeaux
Want to get in touch with this sponsor?
Send a question and we'll pass it on to F2G Limited.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.